Drug profile · INN
atomoxetine
APO-ATOMOXETINE
atomoxetine (APO-ATOMOXETINE) is a norepinephrine transporter inhibitor. Associated with Sandoz Pty Ltd.
TGA: approved
Patents linked 2
Pipeline programs 8
News articles 0
Drug details — atomoxetine
- Class
- —
- Route
- —
- Patents
- 2
- Programs
- 8
- Data quality
- 0.81
Quick answer
atomoxetine (APO-ATOMOXETINE) is a norepinephrine transporter inhibitor. Associated with Sandoz Pty Ltd.
Key facts
INN atomoxetine
Brand APO-ATOMOXETINE
Mechanism Norepinephrine transporter inhibitor
Originator Sandoz Pty Ltd
Mechanism of action
Norepinephrine transporter inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is atomoxetine?
atomoxetine (APO-ATOMOXETINE) is a norepinephrine transporter inhibitor. Associated with Sandoz Pty Ltd.
What is the brand name for atomoxetine?
APO-ATOMOXETINE is a marketed brand name for atomoxetine. Check FDA Drugs@FDA for the current US label holder and prescribing information.